Last reviewed · How we verify
Methylprednisolon, Lidocaine
At a glance
| Generic name | Methylprednisolon, Lidocaine |
|---|---|
| Sponsor | Satasairaala |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- OMT for Adhesive Capsulitis (PHASE4)
- Hoffa's Fat Pad Impingement (HFPI) (PHASE4)
- Combination of Fluoroscopy and Ultrasonography Guidance in Sacroiliac Joint Injections. A Randomised Controlled Trial (NA)
- Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA) (NA)
- Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis (PHASE4)
- IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage (PHASE2)
- Ultrasound-Guided Suprascapular Nerve RFA vs Steroid-Local Anesthetic Injection in Chronic Shoulder Pain (NA)
- A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Methylprednisolon, Lidocaine CI brief — competitive landscape report
- Methylprednisolon, Lidocaine updates RSS · CI watch RSS
- Satasairaala portfolio CI